Search
"Ethanol lock prophylaxis (ELP) greatly reduces CLABSI frequency with minimal side effects" Raghu et al (2021).
Ethanol lock prophylaxis reduces CLABSI rates

Abstract:

Introduction: Central line-associated bloodstream infections (CLABSIs) lead to significant morbidity and mortality in children with intestinal failure (IF). Ethanol lock prophylaxis (ELP) greatly reduces CLABSI frequency with minimal side effects. However, in the United States, a recently approved orphan drug designation for dehydrated alcohol has greatly increased 70% ethanol cost from about $10/day to $1000/day. We examined the cost-effectiveness of ELP in relation to these changes.

Methods: We simulated a previously developed IF Markov model over 1 year. Costs were measured in 2020 US dollars and effectiveness in quality-adjusted life-years (QALYs). CLABSI rate with and without ELP was estimated from the largest available comparative observational study. The primary outcome was incremental cost-effectiveness ratio (ICER) between treatments. Secondary outcomes include CLABSI frequency. Sensitivity analyses on all model parameters were performed.

Results: In the base model, children with IF not using ELP accumulated $131,815 in costs and 0.32 QALYs per patient compared to $437,884 and 0.33 QALYs per patient in those using ELP. The ICER was nearly $18 million/QALY gained. ELP resulted in a 40% reduction in CLABSI frequency. ELP became cost-effective at $68/day and cost-saving at $63/day. Sensitivity analysis identified no other plausible parameter variation to reach the $100,000/QALY gained benchmark.

Conclusions: At the current price, ELP is not cost-effective for CLABSI prevention in children with IF in the United States. This study highlights the critical need for the approval of an affordable lock therapy option to prevent CLABSIs in these children.

Clinical relevancy statement: Central line-associated bloodstream infections result in significant morbidity and mortality for children with intestinal failure. Ethanol lock prophylaxis effectively reduces incidence of catheter-related infections. A recent policy decision has significantly increased the price of ethanol. In this study, we examine the cost-effectiveness of ethanol lock prophylaxis using a simulation model to compare the value to the current cost.

Reference:

Raghu VK, Mezoff EA, Cole CR, Rudolph JA, Smith KJ. Cost-effectiveness of ethanol lock prophylaxis to prevent central line-associated bloodstream infections in children with intestinal failure in the United States. JPEN J Parenter Enteral Nutr. 2021 Apr 28. doi: 10.1002/jpen.2130. Epub ahead of print. PMID: 33908050.

Comments from IVTEAM
Comments from IVTEAM
@ivteam
Read More

Ethanol lock prophylaxis reduces CLABSI rates with minimal side effects. However, its use may be cost prohibitive in the United States. Study authors highlight the need to identify a cost effective lock therapy to prevent CLABSIs.

Click here for more information on ethanol locks and how they interact with catheter materials.